1 - 10 out of 13Page size: 10
  1. 2023

  2. Constitutive Androstane Receptor Agonist Initiates Metabolic Activity Required for Hepatocyte Proliferation

    Mazin, M. E., Perevalova, A. M., Yarushkin, A. A., Pustylnyak, Y. A., Rogachev, A. D., Prokopyeva, E. A., Gulyaeva, L. F. & Pustylnyak, V. O., Aug 2023, In: Biochemistry (Moscow). 88, 8, p. 1061-1069 9 p.

    Research output: Contribution to journal › Article › peer-review

  3. Tumor suppressor PTEN regulation by tobacco smoke in lung squamous-cell carcinoma based on bioinformatics analysis

    Pustylnyak, V. O., Alekseenok, E. Y., Perevalova, A. M., Kozlov, V. V. & Gulyaeva, L. F., Aug 2023, In: Heliyon. 9, 8, 10 p., e19044.

    Research output: Contribution to journal › Article › peer-review

  4. 2022

  5. Role of Tumor Suppressor PTEN and Its Regulation in Malignant Transformation of Endometrium

    Perevalova, A. M., Kobelev, V. S., Sisakyan, V. G., Gulyaeva, L. F. & Pustylnyak, V. O., Nov 2022, In: Biochemistry (Moscow). 87, 11, p. 1310-1326 17 p.

    Research output: Contribution to journal › Review article › peer-review

  6. Promotion of NR1I3-mediated liver growth is accompanied by STAT3 activation

    Mazin, M. E., Yarushkin, A. A., Pustylnyak, Y. A., Prokopyeva, E. A. & Pustylnyak, V. O., May 2022, In: Molecular Biology Reports. 49, 5, p. 4089-4093 5 p.

    Research output: Contribution to journal › Article › peer-review

  7. 2021

  8. miRNA expression and interaction with the 3′UTR of FMR1 in FRAXopathy pathogenesis

    Dolskiy, A. A., Yarushkin, A. A., Grishchenko, I. V., Lemskaya, N. A., Pindyurin, A. V., Boldyreva, L. V., Pustylnyak, V. O. & Yudkin, D. V., Mar 2021, In: Non-coding RNA Research. 6, 1, p. 1-7 7 p.

    Research output: Contribution to journal › Article › peer-review

  9. 2020

  10. Noncanonical constitutive androstane receptor signaling in gene regulation

    Pustylnyak, Y. A., Gulyaeva, L. F. & Pustylnyak, V. O., 14 Sept 2020, In: International Journal of Molecular Sciences. 21, 18, p. 1-10 10 p., 6735.

    Research output: Contribution to journal › Review article › peer-review

  11. Activation of the Akt pathway by a constitutive androstane receptor agonist results in β-catenin activation

    Yarushkin, A. A., Mazin, M. E., Pustylnyak, Y. A., Prokopyeva, E. A. & Pustylnyak, V. O., 15 Jul 2020, In: European Journal of Pharmacology. 879, 5 p., 173135.

    Research output: Contribution to journal › Article › peer-review

  12. 2019

  13. Promotion of liver growth by CAR is accompanied by Akt pathway activation and FoxM1-Nedd4-mediated repression of PTEN

    Yarushkin, A. A., Mazin, M. E., Pustylnyak, Y. A., Prokopyeva, E. A. & Pustylnyak, V. O., 15 Sept 2019, In: Archives of Biochemistry and Biophysics. 672, p. 108065 7 p., 108065.

    Research output: Contribution to journal › Article › peer-review

  14. 2018

  15. CAR-mediated repression of Cdkn1a(p21) is accompanied by the Akt activation

    Yarushkin, A. A., Mazin, M. E., Yunusova, A. Y., Korchagina, K. V., Pustylnyak, Y. A., Prokopyeva, E. A. & Pustylnyak, V. O., 2 Oct 2018, In: Biochemical and Biophysical Research Communications. 504, 2, p. 361-366 6 p.

    Research output: Contribution to journal › Article › peer-review

  16. PTEN negative correlates with miR-181a in tumour tissues of non-obese endometrial cancer patients

    Geletina, N. S., Kobelev, V. S., Babayants, E. V., Feng, L., Pustylnyak, V. O. & Gulyaeva, L. F., 20 May 2018, In: Gene. 655, p. 20-24 5 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 Next

ID: 3444310